Board of Directors

Black Lives Matter | An Important Message from the FDLI Board of Directors

2021 Board Members Announced | Press Release

Daniel Kracov | Read Bio
Partner, Arnold & Porter LLP
Chair

Jennifer L. Bragg | Read Bio
Partner, Skadden, Arps, Slate,
Meagher & Flom LLP
Immediate Past Chair

Freddy A. Jimenez | Read Bio
Senior Vice President and General Counsel, Celldex Therapeutics
Secretary and General Counsel

Frederick R. Ball | Read Bio
Partner, Duane Morris LLP
Treasurer

Amy Comstock Rick | Read Bio
Food and Drug Law Institute
President and CEO

At-Large Directors

Cathy L. Burgess | Read Bio
Partner, Alston & Bird LLP

Carla Cartwright | Read Bio

Senior Director, Global Digital and Regulatory Policy, Johnson & Johnson

Dean R. Cirotta | Read Bio
President, EAS Consulting Group

Jeffrey Francer | Read Bio
Senior Vice President and General Counsel, Association for Accessible Medicines

Melanie Gross | Read Bio
Senior Director & Associate General Counsel, Genentech, Inc.

Sonali P. Gunawardhana | Read Bio
Chief Counsel – FDA & Regulatory Law, McKesson Corporation

Amy Norris | Read Bio
Executive Counsel, Clif Bar & Company

Francis B. Palumbo | Read Bio
Professor & Executive Director, University of Maryland School of Pharmacy, Center on Drugs & Public Policy

Margaret (Mimi) Foster Riley | Read Bio
Professor, University of Virginia, Schools of Law and Medicine

Cynthia Schnedar | Read Bio 
Executive Vice President, Greenleaf Health, Inc.

Rachel Turow | Read Bio 
Associate General Counsel, Regulatory Law & Policy and Head, U.S. Regulatory Policy, TEVA Pharmaceuticals USA, Inc.